Showing 641-650 of 9420 results for "".
Steps for Launching a Product
https://practicaldermatology.com/topics/practice-management/steps-for-launching-a-product/19015/Candace Spann, MD shares her journey launching a new hair care brand and imparts lessons she learned along the way.Educating Patients On OTC Products
https://practicaldermatology.com/topics/practice-management/educating-patients-on-otc-products/19023/Kristina Goldenberg, MD describes how to incorporate patient education into care, particularly the importance of addressing patient misconceptions regarding OTC products.Skincare for Men
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skincare-for-men/19108/Joel L. Cohen, MD talks about the growth in male demand for cosmetics and talks about tips for skincare for men. Male PatientsProcedural Management for HS
https://practicaldermatology.com/programs/practical-dermatology/procedural-management-for-hs/35891/Vivian Shi, MD, talks about procedural management for hidradenitis suppurativa and how to incorporate those procedures with medical management of the condition at Music City SCALE 2025.Novel PsO Drug Could Be 'Closest Perception of a Cure,' Dr. Strober Says at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/novel-pso-drug-could-be-closest-perception-of-a-cure-dr-strober-says-at-maui-derm/32922/A novel monoclonal antibody targeting IL-23 for the treatment of psoriasis offers an extended half-life that will be a key differentiator for patients, according to Bruce Strober, MD, PhD.Dr. Eichenfield Urges Caution for Steroid-Phobia at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-eichenfield-urges-caution-for-steroid-phobia-at-maui-derm/32919/In addition to the various clinical skin conditions that pediatric patients present with, dermatologists now must understand how to deal with steroid-phobia, according to Lawrence Eichenfield, MD.DermWire TV Extra: Dr. Swanson on BPO
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-swanson-bpo/29166/Practical Dermatology Editorial Board member Elizabeth (Lisa) Swanson, MD, FAAD, addresses the recent news involving the safety of benzoyl peroxide products.Vegas Cosmetic Surgery 2016 Update
https://practicaldermatology.com/topics/practice-management/vegas-cosmetic-surgery-2016-update/18764/Highlights from the Vegas Cosmetic Surgery 2016 meeting at the Bellagio hotel. Get insights from speakers: Timothy Miller, MD, Jason Bloom, MD, Jeffrey Spiegel, MD, David Evans, Mara Shorr, BS, CAC II-VII, Donn Chatham, MD, Wendy Lee, MD, Jay Shorr, BA, MBM-C, CAC I-VIII. Topics include neurotoxins,PsA-5T-Ds: A New Psoriatic Arthritis Assessment Tool
https://practicaldermatology.com/topics/psoriasis/psa-5t-ds-a-new-psoriatic-arthritis-assessment-tool/20227/The PsA 5-Thermometer Scale Domains (PsA-5T-Ds) measures patient-reported pain, fatigue, physical function, skin problems, and depression. Here, Philip Mease, MD, discusses the validity of this tool in three Phase 3 studies of guselkumab as well as the role it could play in practice.Journal Club: Tapinarof Cream in Pediatric Patients
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-tapinarof-cream-in-pediatric-patients/32399/Practical Dermatology Editorial Board member Peter Lio, MD, speaks with Mona Shahriari, MD, about the Journal of Dermatology article "A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis," and the general importance of